In the cystic fibrosis airways, MPO acts as a phagocyte-derived NO oxidase that diminishes NO bioavailability and, consequently, its immune protective (anti-bacterial and anti-viral) and anti-inflammatory properties [66]. Here, MPO is linked to cystic fibrosis.